Article Text

PDF
OP0028 Independent and Interactive Effects of Interferon (IFN)-Alpha and the Lupus Risk Haplotype HLA-DRB1*03:01 on Gene Expression in Ex Vivo B Cells
  1. C. Duarte,
  2. T. Vyse,
  3. L. Boteva,
  4. M. Fernando
  1. King's College London, London, United Kingdom

Abstract

Background Systemic lupus erythematosus (SLE) is a complex genetic autoimmune disease characterised by B cell hyperactivity and up-regulation of type I IFN. The DRB1*03:01 extended haplotype confers the greatest genetic risk for SLE in Europeans, but the molecular mechanisms underlying this association are unclear. Both coding and non-coding genetic variants arising from this haplotype may contribute to disease risk, implicating a role for gene regulation. Genetic effects on gene expression are context-specific, depending on factors such as cell type and cell state.

Objectives To investigate the effect of (i) IFN-α stimulation, (ii) DRB1*03:01 haplotypes and (iii) the haplotype-environment interaction between DRB1*03:01 and IFN-α on differential gene expression in ex vivo B cells.

Methods RNA was extracted from ex vivo CD19+ B cells from 50 healthy European women harbouring DRB1*03:01 homozygous (n=17), heterozygous (n=3) and non-DRB1*03:01 (n=30) haplotypes. Gene expression from cells at rest (n=49) and after stimulation with IFN-α for 6 hours (n=33) was quantified using the Affymetrix Human Exon 1.0 ST array. The individual and interactive effects of IFN-α stimulation and the DRB1*03:01 haplotype on gene expression were analysed using a two-way ANOVA (FDR 5%) using Partek Genomics Suite. Pathway and disease enrichment were analysed using Ingenuity Pathway Analysis.

Results 6,906 out of 15,468 genes are significantly differentially expressed in IFN-α-treated compared to resting cells, of which 1,263 have fold changes >2. As expected, the data is enriched for the IFN-α pathway (P=3.4x10-2) and B cell receptor signalling genes (P=2.1x10-12). Approximately 60% of SLE- and rheumatoid arthritis-associated genes from GWAS are significantly enriched in this dataset (PSLE=4.4x10-2, PRA=6.1x10-6), in comparison to the non-autoimmune disease osteoarthritis (20%; POA=0.6). Interestingly, IFN-α affects SLE-associated genes outside canonical type I IFN and B cell signalling pathways, such as ITGAM (P=1.9x10-10, ↓) and PTPN22 (P=4.5x10-10, ↓). Genes implicated in monogenic SLE such as TREX1 and DNASE1L (DNA repair) and C1R (complement pathway) are also differentially expressed on IFN-α stimulation. The only gene significantly differentially expressed between DRB1*03:01 and non-DRB1*03:01 samples is BTN3A2, which is downregulated in DRB1*03:01 haplotypes in both resting (P=2.3x10-2) and IFN-α-treated cells (P=1.2x10-2). Furthermore, BTN3A2 levels differ between DRB1*03:01 and non-DRB1*03:01 individuals in response to IFN-α stimulation, implicating haplotype-environment interactions (Pint=1.4x10-7).

Conclusions Stimulation of B cells with IFN-α influences the expression of genes associated with complex and monogenic forms of SLE not known to be involved in type I IFN or B cell signalling pathways. Individuals harbouring DRB1*03:01 haplotypes demonstrate downregulation of BTN3A2, implicating effects independent of HLA alleles for this risk haplotype. Additionally, we show that IFN-α and DRB1*03:01 interactively downregulate BTN3A2, shedding some light into the mechanism behind the known association of IFN-α exposure with SLE risk. Investigating the effects of disease-associated haplotypes on gene expression in relevant contexts such as IFN-α stimulation may help in resolving genetic associations and identifying candidate genes underlying susceptibility to complex diseases.

Disclosure of Interest None declared

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.